Scanlan Sean F. (CIK 0001856371)

Latest company ownership

TMCI - TREACE MEDICAL CONCEPTS, INC.

Role: Chief Innovation Officer

Shares held

373,599

Last filed at

Oct 28, 2025

Confidence Score

49.7

2025Q4

Confidence Score History

2021Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 17, 2025	Mar 19, 2025	TREACE MEDICAL CONCEPTS, INC.	Chief Innovation Officer	Sell	22.5	-50,000	-12.07%	✓	$398.5K
May 16, 2023	May 18, 2023	TREACE MEDICAL CONCEPTS, INC.	Chief Innovation Officer	Sell	7.5	-25,000	-43.56%	✓	$636K
Mar 9, 2023	Mar 10, 2023	TREACE MEDICAL CONCEPTS, INC.	Chief Innovation Officer	Sell	91.3	+22,420	224.76%	✗	$12.3K
Feb 15, 2023	Feb 17, 2023	TREACE MEDICAL CONCEPTS, INC.	Chief Innovation Officer	Sell	7.5	-25,000	-71.48%	✓	$542.2K
Jan 12, 2023	Jan 13, 2023	TREACE MEDICAL CONCEPTS, INC.	Chief Innovation Officer	Sell	7.5	-25,000	-71.48%	✓	$639.3K
Nov 14, 2022	Nov 16, 2022	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	7.5	-25,000	-71.48%	✓	$606.7K
Mar 2, 2022	Mar 4, 2022	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	7.5	-25,000	-100.00%	✓	$520.6K
Feb 8, 2022	Feb 10, 2022	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	7.5	-25,000	-100.00%	✓	$501K
Jan 10, 2022	Jan 12, 2022	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	7.5	-47,700	-100.00%	✓	$961.4K
Jan 3, 2022	Jan 5, 2022	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	13.8	-2,300	-100.00%	✓	$46K
Nov 10, 2021	Nov 12, 2021	TREACE MEDICAL CONCEPTS, INC.	SVP, Marketing	Sell	7.5	-25,000	-100.00%	✓	$538.4K